Cognition Therapeutics (CGTX) Proxy filing summary

Voting matters and shareholder proposals

• Election of two Class II directors, Aaron Fletcher, Ph.D. and Lisa Ricciardi, for a three-year term expiring in 2029 is up for vote.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for 2026 is proposed.

• Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends voting in favor of both director nominees and the auditor ratification.

Audit committee and external auditor matters

• Proposal to ratify Ernst & Young LLP as the external auditor for the 2026 fiscal year.